A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT07318415
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Multiparametric Ultrasound Imaging — DIAGNOSTIC_TESTmultiparametric ultrasound (mpUS) imaging right before IVRT, right after the last IVRT, and at 3, 6 and 12 months after IVRT
- The vaginal assessment score (VAS) — OTHERThe vaginal assessment score (VAS) is a four-item measure that is administered to the patient to quantify and rate (none, mild, moderate, or severe) their perception of dryness, soreness, irritation, and pain (dyspareunia or painfulness to touch with external stimulation).
Study Details
The researchers are doing this study to see how well multiparametric ultrasound (mpUS) imaging can evaluate vaginal tissue before and after IVRT. IVRT is routinely used to treat endometrial cancer but can cause damage to the vaginal tissue (vaginal toxicity). Side effects of vaginal toxicity can include vaginal dryness, itching, soreness, discharge, narrowing or shortening of the vagina (stenosis), and vaginal fibrosis (hardening), which can affect sexual function. The researchers will also look at whether participants are able to complete (tolerate) all mpUS imaging for this study.
Key Dates
- Start date
- Dec 11, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Multiparametric Ultrasound Imaging (mpUS)All participants in this study will receive standard intravaginal brachytherapy (IVRT) and multiparametric ultrasound (mpUS) imaging right before IVRT, right after the last IVRT, and at 3, 6 and 12 months after IVRT.
Primary Outcome Measure
feasibility of B-mode ultrasound imaging [ Time Frame: 1 year ]
Central Contacts
- Kaled Alektiar, MD212-639-7981
- Mark Burgess, MD
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Consent Only) | Basking Ridge | New Jersey | 07920 | Kalad Alektiar, MD 212-639-7981 |
| Memorial Sloan Kettering Monmouth (Consent Only) | Middletown | New Jersey | 07748 | Kaled Alektiar, MD 212-639-7981 |
| Memorial Sloan Kettering Bergen (Consent Only) | Montvale | New Jersey | 07645 | Kaled Alektiar, MD 212-639-7981 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Commack | New York | 11725 | Kaled Alektiar, MD 212-639-7981 |
| Memorial Sloan Kettering Westchester (Consent Only) | Harrison | New York | 10604 | Kaled Alektiar, MD 212-639-7981 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Kaled Alektiar, MD 212-639-7981 Mark Burgess, PhD |
| Memorial Sloan Kettering Nassau (Consent Only) | Uniondale | New York | 11553 | Kaled Alektiar, MD 212-639-7981 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering at Basking Ridge (Consent Only)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Consent Only)· Middletown, NJMemorial Sloan Kettering Bergen (Consent Only)· Montvale, NJMemorial Sloan Kettering Suffolk - Commack (Consent Only)· Commack, NYMemorial Sloan Kettering Westchester (Consent Only)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersPHASE1/PHASE2 · Recruiting · Regeneron Pharmaceuticals · Birmingham, Alabama
- Vaginal Cuff Brachytherapy Fractionation StudyPHASE3 · Recruiting · Kara Romano, MD · Baltimore, Maryland